IP Library Granted Patent US 9,289,327
Granted Patent B2
US 9,289,327 · App. 13/458,006 · Granted Mar 22, 2016

Open-cavity, reduced-pressure treatment devices and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,289,327
App. No.
13/458,006
Granted
Mar 22, 2016
Kind
B2
Abstract

An open-cavity, reduced-pressure treatment device and system for treating a cavity in a patient's body, such as an abdominal cavity, is presented. In one instance, an open-cavity, reduced-pressure treatment device includes a plurality of encapsulated leg members, each having an interior portion with a leg manifold member and formed with fenestrations operable to allow fluid flow into the interior portion, and a central connection member fluidly coupled to the plurality of encapsulated leg members. The central connection member has a connection manifold member. The open-cavity, reduced-pressure treatment devices, systems, and methods allow for, among other things, removal of fluids.

Claims (27)

1. A method of manufacturing a reduced-pressure treatment device for use in a body cavity of a patient, the method comprising:

forming a plurality of encapsulated leg members, each encapsulated leg member having a longitudinal length and an interior portion with a leg manifold member;

forming a plurality of fenestrations on the encapsulated leg members, the fenestrations positioned along the longitudinal length of the encapsulated leg members and operable to allow fluid flow into the interior portion of the encapsulated leg members;

forming a central connection member having a connection manifold member; and

coupling the central connection member to the plurality of encapsulated leg members, wherein each leg manifold member is in fluid communication with the connection manifold member;

wherein forming a plurality of encapsulated leg members, forming a central connection member having a connection manifold member, and coupling the central connection member to the plurality of encapsulated leg members comprise:

providing a first non-adherent drape,

placing a manifold unit adjacent to a surface of the first non-adherent drape, the manifold unit having a plurality of leg manifold members and a connection manifold member,

placing a second non-adherent drape over the manifold unit, and

coupling the first non-adherent drape and the second non-adherent drape to form the plurality of encapsulated leg members and the central connection member.

2. The method of manufacturing a reduced-pressure treatment device of claim 1 , further comprising placing visual indicia on the first non-adherent drape and the second non-adherent drape that indicate various sizes.

3. The method of manufacturing a reduced-pressure treatment device of claim 1 , wherein forming a plurality of encapsulated leg members, forming a central connection member having a connection manifold member, and coupling the central connection member to the plurality of encapsulated leg members comprise:

cutting the first non-adherent drape and the second non-adherent drape.

4. The method of manufacturing a reduced-pressure treatment device of claim 1 , wherein forming a plurality of encapsulated leg members, forming a central connection member having a connection manifold member, and coupling the central connection member to the plurality of encapsulated leg members comprise:

bonding the first non-adherent drape to the second-adherent drape; and

cutting the first non-adherent drape and the second non-adherent drape.

5. The method of manufacturing a reduced-pressure treatment device of claim 1 , wherein the leg manifold member and the connection manifold member are foam.

6. A method of manufacturing a reduced-pressure treatment device for use in treating a tissue site in a body cavity of a patient, the method comprising:

providing a first non-adherent drape;

providing a second non-adherent drape;

positioning a manifold unit as a layer between the first non-adherent drape and the second non-adherent drape, the manifold unit having a plurality of leg manifold members and a connection manifold member; and

coupling the first non-adherent drape to the second non-adherent drape, thereby providing a plurality of encapsulated leg members in fluid communication with a central connection member, each encapsulated leg member having a longitudinal length.

7. The method of manufacturing a reduced pressure treatment device of claim 6 , wherein coupling the first non-adherent drape to the second non-adherent drape bonds the first and second non-adherent drape to one another around the leg manifold members and the connection manifold member.

8. The method of manufacturing a reduced pressure treatment device of claim 6 , wherein the leg manifold members and the connection manifold member are foam.

9. The method of manufacturing a reduced pressure treatment device of claim 6 , further comprising forming a plurality of fenestrations positioned along the longitudinal length of each encapsulated leg member.

10. The method of manufacturing a reduced pressure treatment device of claim 6 , further comprising cutting the first non-adherent drape and the second non-adherent drape to a desired size.

11. The method of manufacturing a reduced pressure treatment device of claim 6 , wherein a substantial portion of the longitudinal length of each of the encapsulated leg members is configured to contact the tissue site.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066444/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2013
From: BEARD, MARK STEPHEN JAMES; LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK; HARDMAN, IAN JAMES; SEALY, JAMES JOSEPH; HALL, COLIN JOHN; WHYTE, DAVID GEORGE
To: KCI LICENSING, INC.
Reel/Frame 030892/0620 →